Form D — Odyssey Therapeutics, Inc.
0001104659-25-118426 · filed 2025-12-04
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $214,025,200
- Total sold
- $214,025,200
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Odyssey Therapeutics, Inc.
- CIK
- 1882782
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 51 SLEEPER STREET
BOSTON, MA 02210 - Phone
- 617-865-9628
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gary D. Glick · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Carl Gordon · DirectorBoston, MA Find on LinkedIn ↗
-
Jill Carroll · DirectorBoston, MA Find on LinkedIn ↗
-
Valerie Odegard · DirectorBoston, MA Find on LinkedIn ↗
-
Nan Li · DirectorBoston, MA Find on LinkedIn ↗
-
Jeffrey Leiden · DirectorBoston, MA Find on LinkedIn ↗
-
Paulina Hill · DirectorBoston, MA Find on LinkedIn ↗
-
Timothy Walbert · DirectorBoston, MA Find on LinkedIn ↗
-
lan F. Smith · DirectorBoston, MA Find on LinkedIn ↗
-
Shelley Chu · DirectorBoston, MA Find on LinkedIn ↗
-
Ksenija Pavletic · DirectorBoston, MA Find on LinkedIn ↗
-
Carolyn Ng · DirectorBoston, CA Find on LinkedIn ↗
-
Nia Tatsis · DirectorBoston, MA Find on LinkedIn ↗
-
Jason Haas · Executive OfficerBoston, MA Find on LinkedIn ↗
View original on SEC EDGAR.